The onset and aggressiveness of cancer are related to the abnormal behavior of certain genes, known as oncogenes. The ...
News Medical on MSN
Small molecule targets glioblastoma oncogene in preclinical studies
UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, ...
The onset and aggressiveness of cancer are related to the abnormal behaviour of certain genes, known as oncogenes. The best-known of these alterations ...
In cellular and animal models of neuroblastoma, small cell lung cancer and colon cancer, this strategy reduces tumours, ...
Hosted on MSN
Targeting sleeping tumor cells: Oncogene location may determine neuroblastoma's resistance to cancer therapy
Neuroblastoma can be a particularly insidious cancer. In about half of all cases, tumors regress, even without therapy. In the other half, tumors grow very quickly. These tumors often respond well to ...
Perioperative therapy has become a critical component in the management of resectable non–small cell lung cancer (NSCLC), particularly in the era of precision medicine. Although molecular testing is ...
Spanish researchers report a major pancreatic cancer breakthrough in mice, with a triple-drug therapy eliminating tumours by targeting the KRAS pathway, raising hopes for future human trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results